Search research articles
Contact Us
Filters
Showing results (481-490 of 22,557) with videos related to
Page
of 2,256
Sort By:
Oncogene
|
March 14, 2007
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma
E Dahl, F Wiesmann, M Woenckhaus, et al.
Oncogene
|
September 20, 2006
Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway
C G Concannon, B F Koehler, Claus Reimertz, et al.
Oncogene
|
September 20, 2006
Transcription linked to recombination: a gene-internal promoter coincides with the recombination hot spot II of the human MLL gene
S Scharf, J Zech, A Bursen, et al.
Oncogene
|
September 20, 2006
Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation
A Hamaï, C Richon, F Meslin, et al.
Oncogene
|
September 26, 2006
Clinical management of BRCA1 and BRCA2 mutation carriers
S M Domchek, B L Weber
Oncogene
|
September 26, 2006
Modifiers of risk of hereditary breast cancer
S A Narod
Oncogene
|
September 26, 2006
Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects
B Evers, J Jonkers
Oncogene
|
September 26, 2006
The CHEK2 gene and inherited breast cancer susceptibility
H Nevanlinna, J Bartek
Oncogene
|
September 27, 2006
Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia
R S Bindra, P M Glazer
Oncogene
|
September 27, 2006
p53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A
K Rother, R Kirschner, K Sänger, et al.
Page
of 2,256
Search research articles
Search
Showing results (481-490 of 22,557) with videos related to
Sort By:
Page
of 2,256
Oncogene
|
March 14, 2007
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma
E Dahl, F Wiesmann, M Woenckhaus, et al.
Oncogene
|
September 20, 2006
Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway
C G Concannon, B F Koehler, Claus Reimertz, et al.
Oncogene
|
September 20, 2006
Transcription linked to recombination: a gene-internal promoter coincides with the recombination hot spot II of the human MLL gene
S Scharf, J Zech, A Bursen, et al.
Oncogene
|
September 20, 2006
Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation
A Hamaï, C Richon, F Meslin, et al.
Oncogene
|
September 26, 2006
Clinical management of BRCA1 and BRCA2 mutation carriers
S M Domchek, B L Weber
Oncogene
|
September 26, 2006
Modifiers of risk of hereditary breast cancer
S A Narod
Oncogene
|
September 26, 2006
Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects
B Evers, J Jonkers
Oncogene
|
September 26, 2006
The CHEK2 gene and inherited breast cancer susceptibility
H Nevanlinna, J Bartek
Oncogene
|
September 27, 2006
Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia
R S Bindra, P M Glazer
Oncogene
|
September 27, 2006
p53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A
K Rother, R Kirschner, K Sänger, et al.
Page
of 2,256